New: Evolving the Heatmap: Dow Jones, Nasdaq 100, Russell 2000, and More

Learn More
Last Close
Sep 18  •  04:00PM ET
30.97
Dollar change
+0.53
Percentage change
1.74
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y-7.91% Total Holdings66 Perf Week0.58%
SponsorFranklin Templeton ETF Type Tagsequity Return% 3Y-3.54% AUM16.75M Perf Month5.79%
Fund Family Bond Type Tagshealthcare Return% 5Y-1.67% NAV/sh Perf Quarter12.43%
Index- Average Maturity Tagsgenomics Return% 10Y 52W High33.69 -8.07% Perf Half Y10.14%
Index Weighting Commodity Type Tags- Return% SI 52W Low23.74 30.46% Perf YTD7.35%
Active/Passive Quant Type Tags- Flows% 1M9.78% Volatility0.52% 0.61% Perf Year-2.62%
Dividend TTM- ESG Type Tags- Flows% 3M34.56% ATR (14)0.33 Perf 3Y-1.94%
Dividend Ex-DateDec 30, 2021 Dividend Type Sector/Theme Flows% YTD19.78% RSI (14)66.11 Perf 5Y-13.42%
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta1.06 Perf 10Y-
Expense0.50% Growth/Value SMA202.62% Flows% 3Y Rel Volume0.09 Prev Close30.44
Inverse/Leveraged Market Cap SMA506.81% Flows% 5Y Avg Volume7.39K Price30.97
IPOFeb 27, 2020 Option/ShortYes / Yes SMA2008.69% Trades Volume687 Change1.74%
May-02-25 03:25AM
Apr-30-25 04:35AM
Apr-23-25 05:45AM
Apr-20-25 11:28AM
Apr-18-25 01:40PM
08:30AM Loading…
Apr-04-25 08:30AM
Apr-02-25 07:00AM
Apr-01-25 05:40AM
Mar-28-25 06:05AM
Mar-20-25 04:32PM
Jul-16-21 11:19AM
Jan-14-21 09:15AM
Oct-05-20 08:00AM
Franklin Genomic Advancements ETF seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.